Literature DB >> 3666263

Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston).

F J Cornillie1, P Puttemans, I A Brosens.   

Abstract

The histological and ultrastructural changes of ectopic endometrium were studied during treatment with dydrogesterone (Duphaston) in eighteen infertile patients with laparoscopically confirmed endometriosis. Three types of response to therapy, i.e. no response, moderate and good, are detailed. First, focal secretory transformation of the endometriotic epithelium with decidualization of the ectopic stroma was seen in four patients (no response to therapy). In all other patients, the endometriotic implants were undifferentiated (moderate response to therapy) or revealed morphologic features of involution (good response to therapy). Proliferation of endometriotic cells was not seen during treatment with Duphaston, while total eradication of microscopic implants was never observed. Endometriotic implants with good response to Duphaston therapy demonstrated an enhanced autophagic activity within many epithelial cells. Only two patients conceived during a one-year post-treatment follow-up. Both patients demonstrated a good response to therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666263     DOI: 10.1016/0028-2243(87)90008-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.

Authors:  Bo Liang; Ling Wu; Hui Xu; Chun Wai Cheung; Wen Ying Fung; Sze Wai Wong; Chi Chiu Wang
Journal:  Reprod Biol Endocrinol       Date:  2018-04-03       Impact factor: 5.211

2.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

3.  An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study.

Authors:  Jo Kitawaki; Kaori Koga; Takumi Kanzo; Mikio Momoeda
Journal:  Reprod Med Biol       Date:  2021-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.